Sienna Day, DPM
Foot & Ankle Surgery · Viera, FLNPI 1316408594
Payments from drug & device makers
Across 33 payments — averaging $120.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Reel Surgical, Inc.$1K
- Prodigy Surgical Distribution, Inc.$1K
- Treace Medical Concepts, Inc.$634
- Stryker$257
- Smith+Nephew$245
- Heron Therapeutics, Inc.$132
- plus $253 from 7 others
What the payments were for
- Travel & lodging$39810%
- Food & beverage$1,17730%
- Education$2,40060%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Reel Surgical, Inc. | 2 | $1,253 |
| Prodigy Surgical Distribution, Inc. | 1 | $1,200 |
| Treace Medical Concepts, Inc. | 2 | $634 |
| Stryker | 12 | $257 |
| Smith+Nephew | 4 | $245 |
| Heron Therapeutics, Inc. | 1 | $132 |
| Bioventus LLC | 3 | $68 |
| Kerecis Limited | 1 | $48 |
| Averitas Pharma Inc. | 2 | $44 |
| Orthofix Medical, Inc. | 2 | $29 |
| Vertex | 1 | $27 |
| Organogenesis Inc. | 1 | $21 |
| Mimedx Group, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty$398
- RENASYS TOUCH$147
- PICO$147
- Zynrelef$132
How this compares
$3,975 in reported general payments places this provider in the 50th percentile of 850 foot & ankle surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 125 | $2,812 |
| Doxycycline Hyclate | 70 | $527 |
| Methylprednisolone | 41 | $290 |
| Terbinafine Hcl | 18 | $257 |
| Mupirocin | 24 | $191 |
| Gabapentin | 36 | $133 |
| Ciprofloxacin Hcl | 12 | $87 |
| Levofloxacin | 26 | $82 |
| Cephalexin | 16 | $48 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $31 |
| Meloxicam | 16 | $25 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Viera
- Thomas SangiovanniCoral Gables$2.1M
- Shayne JensenPanama City$1.3M
- Thomas RoukisOrlando$1.1M
- Craig BreslauerStuart$971K
- Bradley LammWest Palm Beach$938K
- Amber ShaneOrlando$830K
- Jonathan BlumKissimmee$814K
- Riquel GonzalezHialeah$612K
- Mario CalaHialeah$544K
- Christopher ReevesLake Mary$437K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.